Dr Nidhi Dhariwal

Dr. Nidhi Dhariwal is a paediatric haemato-oncologist and BMT specialist with expertise in managing childhood cancers, haematological disorders, and paediatric bone marrow transplantation. Having trained at premier institutes such as Tata Memorial Hospital and Lady Hardinge Medical College, she has contributed extensively to research in paediatric oncology and has authored several impactful publications. She is committed to delivering compassionate, evidence-based care to children with complex cancers and blood disorders.

Educational Qualifications:

• DM (Paediatric Oncology) – Tata Memorial Hospital, Mumbai (2021)
• MD (Paediatrics) – Lady Hardinge Medical College & Kalawati Saran Children’s Hospital, New Delhi (2016)
• MBBS – Maulana Azad Medical College, New Delhi (2013)

Professional Experience:

• Consultant – Paediatric Haemato-Oncology & BMT, Nanavati Max Hospital, Mumbai (Sept 2025–Present)
• Assistant Professor – Paediatric Oncology, Homi Bhabha Cancer Hospital & Research Centre, New Chandigarh (2022–2025)
• Speciality Registrar – Paediatric Oncology, Tata Memorial Hospital, Mumbai (2021–2022)
• Senior Resident – Paediatric Oncology, Tata Memorial Hospital, Mumbai (2018–2021)
• Senior Resident – General Paediatrics & Neonatology, Kalawati Saran Children’s Hospital, New Delhi (2016–2017)
• Junior Resident – General Paediatrics & Neonatology, Kalawati Saran Children’s Hospital, New Delhi (2013–2016)

Professional Memberships:

• Indian Academy of Pediatrics (IAP)
• Pediatric Hematology & Oncology Chapter (IAP)
• International Society of Paediatric Oncology (SIOP)

Awards & Achievements:

• Recognised for expertise in paediatric cancer care and BMT
• Multiple research contributions in national and international journals
• Active participation in academic and clinical oncology research

Research Papers & Publications:

• Dhariwal N., Srinivasan S., Gollamudi V.R.M., “Acute Myeloid Leukaemia in India: A Systematic Review,” Indian Journal of Medical and Paediatric Oncology.
• Dhariwal N., Moulik N.R., Smriti V., Dhamne C., et al., “Clinico-radiological profile, management and follow-up of methotrexate-induced neurotoxicity in children with acute lymphoblastic leukaemia.”
• Dhariwal N., Moulik N.R., Bhat V., Smriti V., et al., “Intracranial disease in paediatric Hodgkin lymphoma: case report and review of literature.”
• Dhariwal N., Srinivasan S., “Minimal Disseminated Disease continues to impact outcomes in childhood ALK-positive anaplastic large-cell lymphoma: what more can we offer?”
• Srinivasan S., Narayan A., Dhamne C., Chharia A., Khera P., Dhariwal N., et al., “Low-dose nivolumab plus bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma,” British Journal of Haematology.
• Cheriyalinakal Parambil B., Moulik N.R., Dhamne C., Dhariwal N., et al., “COVID-19 in children with cancer and continuation of cancer-directed therapy during infection,” Indian Journal of Pediatrics.
• Raj R., Uppuluri R., Parambil B., Dhariwal N., et al., “Outcomes of COVID-19 in children with cancer: report from the InPOG COVID-19 registry,” Pediatric Hematology Oncology Journal.
• Dhariwal N., Gollamudi V.R.M., Raj S., Cheriyalinakal Parambil K.P.B., et al., “Platelet cancer-associated thrombosis (PCAT): analysis from a tertiary cancer centre in India,” Pediatric Blood & Cancer.